Graessner, Holm http://orcid.org/0000-0001-9803-7183
Reinhard, Carola
Bäumer, Tobias
Baumgärtner, Annette
Brockmann, Knut
Brüggemann, Norbert
Bültmann, Eva
Erdmann, Jeanette
Heise, Kirstin
Höglinger, Günter
Hüning, Irina
Kaiser, Frank J.
Klein, Christine
Klopstock, Thomas
Krägeloh-Mann, Ingeborg
Kraemer, Markus
Luedtke, Kerstin
Mücke, Martin
Musacchio, Thomas
Nadke, Andreas
Osmanovic, Alma
Ritter, Gabriele
Röse, Katharina
Schippers, Christopher
Schöls, Ludger
Schüle, Rebecca
Schulz, Jörg B.
Sproß, Joachim
Stasch, Eveline
Wunderlich, Gilbert
Münchau, Alexander
Funding for this research was provided by:
Damp Stiftung
Bundesministerium für Bildung und Forschung (441409627)
Eberhard Karls Universität Tübingen
Article History
Received: 16 May 2023
Accepted: 11 January 2024
First Online: 13 February 2024
Declarations
:
: Not applicable.
: Not applicable.
: Markus Kraemer received honoraria for teaching activities from Roche Pharma and Chugai Pharma. Dr. Brüggemann received honaria from Abbott, Abbvie, Biogen, Biomarin, Bridgebio, Centogene and Zambon. He is funded by the DFG (BR4328.2–1, GRK1957), and the Michael J Fox Foundation. GH served as a consultant for Abbvie, Alzprotect, Aprineua, Asceneuron, Bial, Biogen, Biohaven, Kyowa Kirin, Lundbeck, Novartis, Retrotope, Roche, Sanofi, UCB; received honoraria for scientific presentations from Abbvie, Bayer Vital, Bial, Biogen, Bristol Myers Squibb, Kyowa Kirin, Roche, Teva, UCB, Zambon.